Literature DB >> 9270825

Three-year follow-up of the European Multicenter Tacrolimus (FK506) Liver Study.

R Pichlmayr1, M Winkler, P Neuhaus, P McMaster, R Calne, G Otto, R Williams, C G Groth, H Bismuth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9270825     DOI： 10.1016/s0041-1345(97)00464-8

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  4 in total

Review 1.  Overview of immunosuppression in liver transplantation.

Authors:  Anjana A Pillai; Josh Levitsky
Journal:  World J Gastroenterol       Date:  2009-09-14       Impact factor: 5.742

Review 2.  Current status of immunosuppression in liver transplantation.

Authors:  Narendra S Choudhary; Sanjiv Saigal; Rajat Shukla; Hardik Kotecha; Neeraj Saraf; Arvinder S Soin
Journal:  J Clin Exp Hepatol       Date:  2013-06-03

3.  Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.

Authors:  G L Plosker; R H Foster
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

Review 4.  Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation.

Authors:  C M Spencer; K L Goa; J C Gillis
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.